Purpose: To examine the prevalence of adherence to hearing aids and determine their rejection causes. Methods: This study was conducted according to the Preferred Reporting terms for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We performed an electronic search using PubMed, BVS, and Embase. Results: 21 studies that met the inclusion criteria were selected. They analyzed a total of 12,696 individuals. We observed that the most common causes for positive adherence to hearing aid use included having a higher degree of hearing loss, patients being aware of their condition, and requiring the device in their daily life. The most common causes for rejection were the lack of perceived benefits or discomfort with the use of the device. The results from the meta-analysis show a prevalence of patients who used their hearing aid of 0.623 (95% CI 0.531, 0.714). Both groups are highly heterogeneous (I2 = 99.31% in each group, p < 0.05). Conclusions: A significant proportion of patients (38%) do not use their hearing aid devices. Homogeneous multicenter studies using the same methodology are needed to analyze the causes of rejection of hearing aids.
Background: Horizontal Canal Cupulolithiasis (hc-BPPV-cu) can mimic a pathology of central origin, so a careful examination is essential to prevent misdiagnosis. Methods: Retrospective cross-sectional cohort study of 45 patients suffering from suspected hc-BPPV-cu. We recorded whether patients first presented through an ENT Emergency Department (ED) or through an Outpatient Otolaryngology Clinic (OC). Results: We found statistically significant differences (p < 0.05) between the OC versus the ED in relation to the time between symptom onset and first assessment (79.7 vs. 3.6 days, respectively), the number of therapeutic maneuvers (one maneuver in 62.5% vs. 75.9%, and more than one in 25.1% vs. 13.7%), and multi-canal BPPV rate (43.8% vs. 3.4%). hc-BPPV-cu did not resolve in 2 patients (12.5%) from the OC and in 3 (10.3%) from de ED, all of which showed central pathology. Discussion: There are no prior studies that analyze the approach to hc-BPPV-cu in the ED. The benefits of early specialist input are early identification of central positional nystagmus, a decrease in symptom duration, reduced number of therapeutic maneuvers required for symptom resolution, and lower rates of iatrogenic multi-canal BPPV. Conclusion: A comprehensive approach to hc-BPPV-cu in the ED allows both more effective treatment and early identification of central disorder mimics.
To analyze the influence of age and cardiovascular risk factors (CVRFs) in the evolution of vestibular neuritis (VN). Methods: Retrospective cohort study. VN-diagnosed patients were included and divided into two groups: those with and without CVRFs. We analyzed the mean vestibular-ocular reflex (VOR) gain, measured through the video head impulse test (vHIT) at the diagnosis and one-year follow-up. We conducted a factorial analysis of variance (ANOVA) to evaluate the effect of age, sex, and CVRFs in the mean VOR gain. Results: Sixty-three VN-diagnosed patients were included. There were no statistically significant differences in the mean VOR gain between both groups. However, in the subgroup analysis, there were statistically significant differences when comparing the mean VOR gain at the one-year follow-up between the group over 55 years of age 0.77 ± 0.20 and the group under 55 years 0.87 ± 0.15 (p = 0.036). Additionally, the factorial ANOVA demonstrated a significant main effect of age group on the mean VOR gain at the one-year follow-up (p = 0.018), and it also found a significant interaction between the factors of gender, age group, HTN (p = 0.043). Conclusions: CVRFs do not independently affect the mean VOR gain in VN patients’ follow-ups. However, age significantly impacts VOR gain in VN and could be modulated by gender and hypertension.
Introduction and objective: Meniere's disease (MD) is a chronic auditory pathology characterized by the presence of hearing loss, episodic dizziness and tinnitus. The objective of this studie is to value the hearing improvement and the reduction of vertiginous crises in patients with Meniere acute accent s disease after the administration of intratympanic corticosteroids (ITS). Method: Retrospective cohort study of a sample of 55 patients diagnosed with definitive Meniere's disease and treated with intratympanic corticosteroids. Results: Of the 39 patients who were treated with ITS for vertigo attacks, one month into the treatment, 27 had no attacks, 11 experienced a few ( 10). There were 16 patients treated with ITS for hearing loss and they reflected a mean hearing loss of 46.61 dB prior to the treatment. One month after the injection, the mean loss was 42.77 dB (1.84) and at six months it was 41.66 dB (2.95). Discussion: The audiometric benefit obtained is approximate to 3 dB und a clear decrease in the number of vertiginous crises after ITS, other authors in their studies have obtained results similar to ours. Conclusions: Our results show that intratympanic corticosteroids is an effective therapy for the control of vertiginous crises and hearing loss.
Introducción y objetivo: Los tumores de cabeza y cuello representan el sexto tipo de cáncer más frecuente y suelen diagnosticarse en estadios avanzados, lo que condiciona la supervivencia. La tomografía por emisión de positrones combinada con tomografía computarizada (18F-FDG PET/TC) es una herramienta eficaz para detectar enfermedad subclínica, metástasis ocultas y tumores sincrónicos, especialmente en pacientes con alto riesgo o antecedentes oncológicos. Su integración con otras modalidades diagnósticas mejora la precisión en la estadificación TNM, optimiza la planificación terapéutica y reduce procedimientos invasivos. El objetivo de este estudio fue evaluar la utilidad del PET/TC en la estadificación inicial, el seguimiento y la detección de tumores sincrónicos en pacientes con cáncer de cabeza y cuello. Método: Estudio retrospectivo de 100 pacientes con cáncer de cabeza y cuello sometidos a PET/TC como parte de la evaluación inicial. Se analizaron variables clínicas, histológicas y metabólicas incluyendo el valor de captación tumoral (SUV tumoral) y el valor de captación en ganglios linfáticos (SUV nodal), así como los cambios en la estadificación y el tratamiento derivados de los hallazgos metabólicos. Resultados: Predominó el sexo masculino (90 %) y el carcinoma epidermoide (84 %). Los síntomas más frecuentes fueron disfonía, odinofagia y adenopatía, con localización supraglótica y orofaríngea. El PET/TC modificó el estadio TNM en el 42 % y el plan terapéutico en el 15 % de los pacientes, detectando además metástasis no identificadas clínicamente y nueve tumores sincrónicos. Se observó concordancia con la anatomía patológica en 57 casos, destacando su utilidad en la planificación del tratamiento. Discusión: La 18F-FDG PET/TC mostró alta sensibilidad en la detección de tumores de cabeza y cuello, aunque limitada en lesiones pequeñas o submucosas. Su integración con TC y RM mejora la precisión diagnóstica y la planificación terapéutica. Los valores elevados de captación tumoral (SUV tumoral) y ganglionar (SUV nodal) observados podrían asociarse con peor pronóstico. La principal limitación del estudio fue su diseño retrospectivo sin grupo control. Conclusiones: La 18F-FDG PET/TC es una herramienta valiosa en la estadificación inicial del cáncer de cabeza y cuello, permitiendo modificar el estadio en el 42 % y el tratamiento en el 15 % de los casos. Su alto valor predictivo negativo (>99 %) contribuye a evitar procedimientos invasivos durante el seguimiento. La detección de tumores sincrónicos refuerza la necesidad de confirmación histológica sistemática.